1.Patient who provides written informed consent <br/ >2.Male or non-pregnant, non-lactating female aged â?¥ 18 and â?¤ 75 years (both inclusive) <br/ >3.RT-PCR confirmed diagnosis of COVID-19 <br/ >4.Able to take the drug orally and comply with study procedures <br/ >5.Women of childbearing potential must have a negative urine pregnancy test prior to study entry <br/ > <br/ >

1.Patient who provides written informed consent <br/ >2.Male or non-pregnant, non-lactating female aged â?¥ 18 and â?¤ 75 years (both inclusive) <br/ >3.RT-PCR confirmed diagnosis of COVID-19 <br/ >4.Able to take the drug orally and comply with study procedures <br/ >5.Women of childbearing potential must have a negative urine pregnancy test prior to study entry <br/ > <br/ >

1.Patient who provides written informed consent <br/ >2.Male or non-pregnant, non-lactating female aged â?¥ 18 and â?¤ 75 years (both inclusive) <br/ >3.RT-PCR confirmed diagnosis of COVID-19 <br/ >4.Able to take the drug orally and comply with study procedures <br/ >5.Women of childbearing potential must have a negative urine pregnancy test prior to study entry <br/ > <br/ >

1.Patient who provides written informed consent <br/ >2.Male or non-pregnant, non-lactating female aged â?¥ 18 and â?¤ 75 years (both inclusive) <br/ >3.RT-PCR confirmed diagnosis of COVID-19 <br/ >4.Able to take the drug orally and comply with study procedures <br/ >5.Women of childbearing potential must have a negative urine pregnancy test prior to study entry <br/ > <br/ >